BNP Paribas Easy (BLUE) | Stock Overview & Key Data

BNP Paribas Easy ECPI Global ESG Blue Economy UCITS ETF | Mid-cap | Healthcare

€15.91

0.05%

| BNP Paribas Easy Stock Comparison:

BNP Paribas Easy vs Medincell S.A BNP Paribas Easy vs Valneva SE BNP Paribas Easy vs Abivax SA BNP Paribas Easy vs Inventiva S.A BNP Paribas Easy vs Viridian BNP Paribas Easy vs CAC 40 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

BNP Paribas Easy Performance Comparison

Loading chart data...

BNP Paribas Easy

CAC 40

View Full Price History

Stock Range

Today's Range

Low: €15.90 High: €15.91

on June 17, 2025

52 Week Range

Low: €13.83 High: €16.93

on April 7, 2025

on October 17, 2024

All-Time High: €40.48 on June 30, 2014

Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights

Key Statistics

Market Cap i €463.8M

EPS i N/A

P/E Ratio (TTM) i 16.15

Forward P/E i N/A

P/B Ratio i N/A

PEG Ratio i N/A

Div. Yield i 0.00%

ROE i -96.39%

Beta i N/A

Debt to Equity i 2.22

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i -156.86%

Profit Margin i -27.22%

Returns and Earnings

Return on Assets (TTM) i -23.08%

Return on Equity (TTM) i -96.39%

EBITDA i €0

Net Income (TTM) i €-42.9M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i N/A

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
BNP Paribas Easy BLUE	463.81M Mid-cap	0.06%	-2.09%	0.63%	-3.11%	-2.87%	-3.34%	18.75%	-6.47%
Medincell S.A MEDCL	516.86M Mid-cap	-3.19%	1.18%	11.44%	-5.78%	-11.69%	10.83%	183.49%	78.41%
Valneva SE VLA	462.57M Mid-cap	-3.75%	-10.45%	-19.94%	46.02%	11.26%	-20.12%	-67.00%	-34.99%
Abivax SA ABVX	390.31M Mid-cap	-15.81%	5.95%	-0.35%	-19.94%	-21.70%	-51.10%	-45.27%	-71.76%
Inventiva S.A IVA	412.43M Mid-cap	-5.00%	-0.35%	3.26%	28.96%	35.07%	5.42%	-58.87%	-25.13%
Viridian VIRI	415.35M Mid-cap	13.07%	9.20%	-6.60%	29.09%	11.19%	16.12%	-37.70%	-44.68%

Ownership & Short Interest

Insider Ownership i N/A

Institutional Ownership i N/A

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 5K

Average 90-Day Volume i 3K

BNP Paribas Easy Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in BNP Paribas Easy would have performed over time.

Investment Amount

€

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BLUE's 52-week high and low?

In the last 52 weeks, BNP Paribas Easy reached a high of €16.93 (on October 17, 2024) and a low of €13.83 (on April 7, 2025).

What is the market cap and P/E ratio for BLUE?

Curious about BNP Paribas Easy's size and valuation? Its market capitalization stands at 463.81M. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.15, and the forward P/E (looking ahead) is N/A.

Does BLUE pay dividends? If so, what's the yield?

As for dividends, BNP Paribas Easy isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is N/A.

Who are BNP Paribas Easy's main competitors or similar companies to consider before investing?

When looking at BNP Paribas Easy, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Medincell S.A MEDCL	516.86M	Healthcare	Biotechnology	10.83%	183.49%
Valneva SE VLA	462.57M	Healthcare	Biotechnology	-20.12%	-67.00%
Abivax SA ABVX	390.31M	Healthcare	Biotechnology	-51.10%	-45.27%
Inventiva S.A IVA	412.43M	Healthcare	Biotechnology	5.42%	-58.87%
Viridian VIRI	415.35M	Healthcare	Biotechnology	16.12%	-37.70%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for BNP Paribas Easy ECPI Global ESG Blue Economy UCITS ETF? (e.g., ROE, Debt/Equity)

To get a sense of BNP Paribas Easy's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -96.39%, the Debt to Equity ratio from the most recent quarter is 2.22, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for BLUE?

Looking at BNP Paribas Easy's growth, its revenue over the trailing twelve months (TTM) was €26M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of BLUE stock is held by insiders and institutions?

Wondering who owns BNP Paribas Easy stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.